HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers chemical drugs, traditional Chinese medicine, biological products, and medical supplies; medical instruments, traditional Chinese medicine decoction pieces, health foods, daily necessities, glassware, and chemical reagents, etc.; It serves its products through e-commerce platforms, direct sales, and a chain of direct stores and online B2C, O2O, etc. The company was founded in 1950 and is headquartered in Harbin, China. HPGC Renmintongtai Pharmaceutical Corporation is a subsidiary of Harbin Pharmaceutical Group Co., Ltd.
Frequently asked questions
What sector does HPGC Renmintongtai Pharmaceutical Corp (600829) operate in?
HPGC Renmintongtai Pharmaceutical Corp belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is HPGC Renmintongtai Pharmaceutical Corp (600829) current stock price?
As of the latest data, HPGC Renmintongtai Pharmaceutical Corp stock price is CN¥9.62, with a previous close of CN¥9.69. HPGC Renmintongtai Pharmaceutical Corp lost -CN¥0.07 in the last trading session, representing a -0.72% loss.
What is HPGC Renmintongtai Pharmaceutical Corp (600829) current market capitalization?
HPGC Renmintongtai Pharmaceutical Corp market cap is approximately 5.58 billion.
What is HPGC Renmintongtai Pharmaceutical Corp (600829) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.25.
What is HPGC Renmintongtai Pharmaceutical Corp (600829) Price-to-Earnings (P/E) ratio?
HPGC Renmintongtai Pharmaceutical Corp current P/E ratio is 38.48.
Does HPGC Renmintongtai Pharmaceutical Corp (600829) pay dividends?
No. HPGC Renmintongtai Pharmaceutical Corp does not pay a dividend.
What is HPGC Renmintongtai Pharmaceutical Corp (600829) beta (volatility) score?
HPGC Renmintongtai Pharmaceutical Corp has a beta of 0.052, indicating lower volatility than the overall market.
